Diseases of the Colon & Rectum

, Volume 39, Issue 9, pp 1051–1054 | Cite as

Xanthogranulomatous cystitis as a cause of elevated carcinoembryonic antigen mimicking recurrent colorectal cancer

Report of a case
  • Agustin A. Garcia
  • Barbara D. Florentine
  • Anthony J. Simons
  • Eila C. Skinner
  • Lawrence W. Leichman
Case Reports
  • 11 Downloads

Abstract

We report a case of xanthogranulomatous cystitis that developed in a patient with a history of colon cancer. While undergoing adjuvant chemotherapy with fluorouracil and levamisole, rising carcinoembryonic antigen (CEA) levels and the appearance of a pelvic mass, suspicious for recurrent cancer, were identified. Exploratory laparotomy demonstrated the presence of a benign condition of the bladder, xanthogranulomatous cystitis, which was resected by partial cystectomy. CEA levels have normalized. This is the first reported case of xanthogranulomatous cystitis producing an elevated CEA level.

Key words

Xanthogranulomatous cystitis Carcinoembryonic antigen Colon cancer recurrence 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Bormer OP. Immunoassays for carcinoembryonic antigen: specificity and interferences. Scand J Clin Lab Invest 1993;53:1–9.PubMedGoogle Scholar
  2. 2.
    Fletcher RH. Carcinoembryonic antigen. Ann Intern Med 1986;104:66–73.PubMedGoogle Scholar
  3. 3.
    Sugarbaker PH, Gianola FJ, Dwyer A, Neuman NR. A simplified plan for follow-up of patients with colon and rectal cancer supported by prospective studies of laboratory and radiologic test results. Surgery 1987;102:79–87.PubMedGoogle Scholar
  4. 4.
    Wang JY, Tang R, Chiang JM. Value of carcinoembryonic antigen in the management of colorectal cancer. Dis Colon Rectum 1994;37:272–7.PubMedGoogle Scholar
  5. 5.
    Thirlby RC. Should you be following carcinoembryonic antigen levels in your patients with colon cancer. Gastroenterology 1994;106:546–9.PubMedGoogle Scholar
  6. 6.
    Moertel CG, Fleming TR, Macdonald JS,et al. An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer. JAMA 1993;270:943–7.PubMedGoogle Scholar
  7. 7.
    Kievit J, van de Velde CJ. Utility and cost of carcinoembryonic antigen monitoring in colon cancer follow-up evaluation. Cancer 1990;65:2580–7.PubMedGoogle Scholar
  8. 8.
    Kaim A, Cathomas G, Kirsch E, Schmid HP, Steinbrich W. Xanthogranulomatous pyelonephritis with phlegmonous abdominal wall infiltration: diagnosis and assessment of extent via computerized tomography. Dtsch Med Wochenschr 1995;120:168–72.CrossRefPubMedGoogle Scholar
  9. 9.
    Case Records of the Massachusetts General Hospital (Case 2-1995). N Engl J Med 1995;332:174–9.Google Scholar
  10. 10.
    Hill GS. Uropathology. New York: Churchill Livingstone, 1989:392–404.Google Scholar
  11. 11.
    Walther M, Glenn JF, Vellios F. Xanthogranulomatous cystitis. J Urol 1985;134:745–6.PubMedGoogle Scholar
  12. 12.
    Tan LB, Chiang CP, Huang CH, Chian CH. Xanthogranulomatous cystitis: a case report and review of the literature. Int Urol Nephrol 1994;26:413–7.PubMedGoogle Scholar
  13. 13.
    Moertel CG, Fleming TR, Macdonald JS, Haller DG, Lavine JA. Hepatic toxicity associated with fluorouracil plus levamisole adjuvant therapy. J Clin Oncol 1993;11:2386–90.PubMedGoogle Scholar

Copyright information

© American Society of Colon and Rectal Surgeons 1996

Authors and Affiliations

  • Agustin A. Garcia
    • 1
  • Barbara D. Florentine
    • 2
  • Anthony J. Simons
    • 3
  • Eila C. Skinner
    • 4
  • Lawrence W. Leichman
    • 1
  1. 1.Department of Medical OncologyUniversity of Southern California School of MedicineLos Angeles
  2. 2.Department of PathologyUniversity of Southern California School of MedicineLos Angeles
  3. 3.Department of SurgeryUniversity of Southern California School of MedicineLos Angeles
  4. 4.Department of UrologyUniversity of Southern California School of MedicineLos Angeles

Personalised recommendations